Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Mitigating the Risk of Infectious Diseases Among Rural Drug Users in Western North Carolina

Results of the Southern Appalachia Test, Link, Care (SA‐TLC) Health Care Provider Survey

Bibliographic Data

ID19432183
AuthorsChristopher B Hurt (0000-0003-3290-8200, Institute for Global Health & Infectious Diseases University of North Carolina at Chapel Hill Chapel Hill North Carolina), Delesha M Carpenter (0000-0003-2025-8140, Division of Pharmaceutical Outcomes and Policy Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina), Donna M Evon (0000-0002-1414-1846, Division of Gastroenterology & Hepatology Department of Medicine University of North Carolina at Chapel Hill Chapel Hill North Carolina), Caitlin M Hennessy (0000-0002-3614-5514, RTI International Research Triangle Park North Carolina), Sarah K Rhea (RTI International Research Triangle Park North Carolina), Sarah Rhea (0000-0002-6183-1620, RTI International), William A Zule (0000-0002-6781-1030, RTI International Research Triangle Park North Carolina)
Year2020
Volume36
Issue2
Pages208-216
Publication date2020-03-01
Open AccessYes
TypeARTICLE
VenueThe Journal of Rural Health (JOURNAL)
Journal identifiersISSN: 0890-765X • E-ISSN: 1748-0361
PublisherWiley (PUBLISHER • GB)
DOI10.1111/jrh.12409
PMID31742771
OpenAlexW2990585937
LanguageEN
Citations received2
References cited20

PURPOSE: To characterize how health care providers in western North Carolina (NC) manage patients with substance use disorders and to inform strategies for preventing injection drug use (IDU)-associated outbreaks of bloodborne infectious diseases. METHODS: We collected data on practice characteristics, provider sociodemographics, and attitudes and beliefs about hepatitis C virus (HCV), human immunodeficiency virus (HIV), opioid use, and IDU via online survey. Providers in 8 counties of western NC were invited to participate by email. Results were analyzed using descriptive and bivariate statistics. FINDINGS: Of 84 respondents participating between 30 July and 3 December 2018, 81% were practicing clinicians and 46% served a county identified as being vulnerable to IDU-associated outbreaks of HCV or HIV. A substantial proportion was unsure about injecting behaviors among patients. Scores reflected comfort working with opioid users, though this varied by medical specialty. One-quarter of respondents "never" discussed harm reduction or HCV treatment with patients known to inject drugs; 22% "never" discussed HIV screening with injectors; and 1 in 3 referred at-risk patients out for HCV or HIV testing rather than ordering a test themselves. Scores indicated low levels of stigma toward persons living with HCV or HIV. Respondents identified HIV treatment, HCV treatment, and liver disease management as training needs. CONCLUSIONS: Our findings provide insights to inform health infrastructure improvement, with the goal of preventing HCV or HIV outbreaks in southern Appalachia. Rural health care workers are willing to receive additional training if it can improve care for patients affected by substance use disorders

Environmental health · Family medicine · Harm reduction · Health care · Hepatitis C · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Opioid Use Disorder Treatment · Pharmacy · Virology

  • Health care stigmatization of substance misuse

    Rhiane Shupe•Journal of Social Work Practice…•2025

  • Covid‐19 and Rural Harm Reduction Challenges in the US Southern Mountains

    Open Access•B Ostrach, Lesly‐Marie Buer et al.•The Journal of Rural Health•2021

  • The 12 Item Social and Economic Conservatism Scale (Secs)

    Open Access•Jim A C Everett, Pete Roma•PLoS ONE•2013

  • HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015

    Philip J Peters, Pamela Pontones et al.•New England Journal of Medicine•2016

  • County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States

    Michelle M Van Handel, Charles E Rose et al.•JAIDS Journal of Acquired Immune…•2016

  • Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014

    Open Access•Rose A Rudd, Noah Aleshire et al.•MMWR. Surveillance Summaries•2016

  • HIV-Related Stigma Among Healthcare Providers in the Deep South

    Open Access•Kristi L Stringer, Bulent Turan et al.•AIDS and Behavior•2015

  • WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs

    Open Access•Nick Walsh, Annette Verster et al.•International Journal of Drug…•2014

  • Population Size Estimates for Men who Have Sex with Men and Persons who Inject Drugs

    Open Access•Alexandra M Oster, Meir Sternberg et al.•Journal of Urban Health•2015

  • Risk Factors for HCV Infection Among Young Adults in Rural New York Who Inject Prescription Opioid Analgesics

    Jon E Zibbell, Jon Zibbell et al.•American Journal of Public Health•2014

  • Negotiating substance use stigma

    Open Access•Jamie Chang, Leslie Dubbin et al.•Sociology of Health & Illness•2016

Citations per year0.4
Citation span2021 - 2025 (5)
Highly citedNo

Tools

Open DOISci-HubOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae